IDEAS home Printed from
MyIDEAS: Log in (now much improved!) to follow this author

Samira Guennif

This is information that was supplied by Samira Guennif in registering through RePEc. If you are Samira Guennif, you may change this information at the RePEc Author Service. Or if you are not registered and would like to be listed as well, register at the RePEc Author Service. When you register or update your RePEc registration, you may identify the papers and articles you have authored.

Personal Details

First Name:Samira
Middle Name:
Last Name:Guennif
RePEc Short-ID:pgu273
Paris, France

: 33 (0)1 49 40 33 18
01 49 40 33 34
99, avenue Jean-Baptiste Clément, 93430 Villetaneuse
RePEc:edi:cep13fr (more details at EDIRC)
in new window
  1. Guennif, Samir & Ramani, Shyama, 2010. "Catching up in pharmaceuticals: a comparative study of India and Brazil," MERIT Working Papers 019, United Nations University - Maastricht Economic and Social Research Institute on Innovation and Technology (MERIT).
  2. Samira Guennif, 2009. "Aids In India," Working Papers id:1974, eSocialSciences.
  3. Samira Guennif, 2007. "Enjeux de santé publique sous gouvernance globale de la propriété intellectuelle. De l'usage des flexibilités prévues par l'ADPIC au Sud," CEPN Working Papers halshs-00176508, HAL.
  4. Samira Guennif, 2007. "Protection du brevet et promotion de la santé publique selon les accords de libre échange états-uniens : surenchères autour des standards minimums de l'AADPIC au Sud," CEPN Working Papers halshs-00176509, HAL.
  5. Valérie Revest & Samira Guennif, 2005. "Social structure and reputation: the NASDAQ case study," Post-Print halshs-00163731, HAL.
  1. Shyama V. Ramani & Samira Guennif, 2012. "Catching up in the Pharmaceutical Sector: Lessons from Case Studies of India and Brazil," Chapters,in: Economic Development as a Learning Process, chapter 5 Edward Elgar Publishing.
  2. Kenneth C. Shadlen & Samira Guennif & Alenka Guzmán & N. Lalitha, 2011. "Globalization, Intellectual Property Rights, and Pharmaceuticals: Meeting the Challenges to Addressing Health Gaps in the New International Environment," Chapters,in: Intellectual Property, Pharmaceuticals and Public Health, chapter 1 Edward Elgar Publishing.
  3. Samira Guennif, 2011. "Access to Essential Drugs in Thailand: Intellectual Property Rights and Other Institutional Matters Affecting Public Health in a Developing Country," Chapters,in: Intellectual Property, Pharmaceuticals and Public Health, chapter 11 Edward Elgar Publishing.
  1. Kenneth C. Shadlen & Samira Guennif & Alenka Guzmán & Narayanan Lalitha (ed.), 2011. "Intellectual Property, Pharmaceuticals and Public Health," Books, Edward Elgar Publishing, number 13876.
NEP is an announcement service for new working papers, with a weekly report in each of many fields. This author has had 3 papers announced in NEP. These are the fields, ordered by number of announcements, along with their dates. If the author is listed in the directory of specialists for this field, a link is also provided.
  1. NEP-CWA: Central & Western Asia (1) 2009-05-30
  2. NEP-FMK: Financial Markets (1) 2007-08-08

Most cited item

Most downloaded item (past 12 months)

Access and download statistics for all items

Co-authorship network on CollEc

For general information on how to correct material on RePEc, see these instructions.

To update listings or check citations waiting for approval, Samira Guennif should log into the RePEc Author Service

To make corrections to the bibliographic information of a particular item, find the technical contact on the abstract page of that item. There, details are also given on how to add or correct references and citations.

To link different versions of the same work, where versions have a different title, use this form. Note that if the versions have a very similar title and are in the author's profile, the links will usually be created automatically.

Please note that most corrections can take a couple of weeks to filter through the various RePEc services.

This information is provided to you by IDEAS at the Research Division of the Federal Reserve Bank of St. Louis using RePEc data.